Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum Disorder
Clinical trial NCT03494738 · COMPLETED
Trial details
- NCT number
- NCT03494738
- Sponsor
- CAMC Health System
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-04-12
- Primary completion
- 2022-12-31
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.